跳至主要内容
临床试验/CTRI/2023/10/058621
CTRI/2023/10/058621尚未招募2 期

Accelerated Hypofractionated Palliative Radiotherapy Vs Standard Hypofractionated Palliative Radiotherapy With Concurrent Chemotherapy In Locally Advanced Head And Neck Carcinoma: A Randomised Controlled Study - nil

AIIMS, New Delhi0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Treatment naive, Histo-pathologically proven Squamous Cell Carcinoma of head and neck region excluding nasopharyngeal, para-nasal sinus and salivary gland primary
  • -Defined as incurable or palliative intent by Head and Neck multidisciplinary team (MDT)
  • -Adequate organ functions and bone marrow reserve
  • -Eastern Co-operative Oncology Group Performance Score (ECOG PS)- (0-3)
  • -Age: 18- 70 years
  • -Negative viral serology markers (HIV, HBsAg, HCV)
  • -Giving written Informed consent

排除标准

  • -Nasopharyngeal, para-nasal sinus or salivary gland primary
  • -Recurrent disease
  • -Metastatic disease
  • -Patients who have previously received oncologic treatment with surgery, radiotherapy or chemotherapy
  • -Pregnant patients
  • -Synchronous malignancy or any other malignancy with in last 5 years
  • -Known uncontrolled medical comorbidities which could impact QOL

研究者

发起方
AIIMS, New Delhi

相似试验